Cargando…
Novel risk genes and mechanisms implicated by exome sequencing of 2572 individuals with pulmonary arterial hypertension
BACKGROUND: Group 1 pulmonary arterial hypertension (PAH) is a rare disease with high mortality despite recent therapeutic advances. Pathogenic remodeling of pulmonary arterioles leads to increased pulmonary pressures, right ventricular hypertrophy, and heart failure. Mutations in bone morphogenetic...
Autores principales: | Zhu, Na, Pauciulo, Michael W., Welch, Carrie L., Lutz, Katie A., Coleman, Anna W., Gonzaga-Jauregui, Claudia, Wang, Jiayao, Grimes, Joseph M., Martin, Lisa J., He, Hua, Shen, Yufeng, Chung, Wendy K., Nichols, William C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857288/ https://www.ncbi.nlm.nih.gov/pubmed/31727138 http://dx.doi.org/10.1186/s13073-019-0685-z |
Ejemplares similares
-
Correction to: Novel risk genes and mechanisms implicated by exome sequencing of 2572 individuals with pulmonary arterial hypertension
por: Zhu, Na, et al.
Publicado: (2022) -
Rare variants in SOX17 are associated with pulmonary arterial hypertension with congenital heart disease
por: Zhu, Na, et al.
Publicado: (2018) -
2572. The Impact of Antibiotics on the Composition of the Vaginal Microbiota
por: Sharara, Sima L, et al.
Publicado: (2019) -
Correction to: Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH
por: Zhu, Na, et al.
Publicado: (2021) -
Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH
por: Zhu, Na, et al.
Publicado: (2021)